Delivering Value To Those We Serve

Overview

Recent News

Date Title and Summary
Toggle Summary Assertio to Present at Cantor Virtual Global Healthcare Conference on September 16, 2020
LAKE FOREST, Ill. , Sept. 09, 2020 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a commercial-stage pharmaceutical company, announced that the company will present at and participate in investor meetings at the Cantor Virtual Global Healthcare Conference
Toggle Summary Assertio Reports Second Quarter 2020 Financial Results
--Completed all merger and integration activities in Q2-- --Repaid $10 million of Senior Secured Notes ahead of schedule-- --Zyla products partially contributed to Q2 net product sales of $20.2 million -- --Combined second quarter 2020 net product sales of $27.7 million , on a pro forma basis,
Toggle Summary Assertio to Release Second Quarter 2020 Financial Results and Host Webcast on August 7, 2020
LAKE FOREST, Ill. , July 20, 2020 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio”) (Nasdaq: ASRT), a commercial-stage pharmaceutical company, today announced that its second quarter 2020 financial results will be released on Friday, August 7, 2020 .

Upcoming Events

There are currently no events to display.
Presentations

IR Contact

Transfer Agent

Continental Stock Transfer & Trust Company
17 Battery Place, 8th Floor
New York, NY 10004
Phone: 800.509.5586
http://www.continentalstock.com
 

Independent Registered Public Accounting Firm

Ernst & Young LLP
Palo Alto, CA
 

Investor Relations Contact

investor@assertiotx.com